Home
overview

For the latest COVID-19 Travel restrictions and recommendations please click here

SAE Media Group’s Inaugural Conference
Medical Devices and IVD
14th - 15th November, 2022 | London, UK
------------------------------------------------------------------------

SAE Media Group is proud to announce the launch of their Medical Devices and IVD conference to be held in London in November 2022.

The MDR implementation last May has highlighted issues within the industry that need to be addressed and the upcoming IVDR updates will have a profound impact on the medical device industry, bringing certain products into regulatory scope that were previously excluded, introducing new manufacturing requirements, and increasing the burden for post-market surveillance.

SAE Media Group's inaugural Medical Devices and IVD conference will provide insight into the latest updates in EU MDR and IVDR regulations and will discuss strategies for how to best comply with these regulations. In addition, the conference will consider the evolving regulatory landscape for digital health software. Join this Medical Device and IVD Conference which will address post-market surveillance and vigilance, clinical evaluations and investigations, medical device regulatory affairs in global markets, and much more.
 

 

 

  • Engage with notified body and competent authority representatives addressing key MDR and IVDR requirements
  • Gain insights from pharma regulatory experts in compliance and companion diagnostics
  • Understand the latest guidance on IVD Regulations to overcome common challenges, in addition to considering evolving global regulations
  • Examine post-market expectations for surveillance and vigilance of your medical devices
  • Delve into advancements in the digitalisation of medical devices and the regulatory considerations surrounding this


 

Executives, Directors, VPs, Heads, Principals, Managers of:

Device Manufacturing
Regulatory Affairs
IVDR
MDR
CMC
Compliance
Risk Management
Traceability
Vigilance
Product Development
PFS
Combination Products
Previous attendees include:
 

Adams Business Associates; Alere International; Alere UK (Rebranded from Inverness Medical UK); AstraZeneca; Bayer A G; BIOAXXESS Technology; Biokit S A; BioKit SA; Boehringer Ingelheim Microparts Gmbh; Cambridge Isotope Laboratories Inc.; Euro Diagnostica; Fleet Bioprocessing Ltd; Index Ventures; Innovate UK (formerly:Technology Strategy Board); Integrated Medicines; Irish Medicines Board; Life Technologies; Medical Device Consultancy; National Genetics Reference Lab, Manchester; NHS Innovations London; NHS Institute for Innovation and Improvement; Pharma Ventures; Point-2-Point Genomics Ltd; QuantumDX; Quotient Bioresearch; Roche Diagnostics Ltd; Royal Free Hospital; Scientia Advisors; Simon-Kucher & Partners; Technology Networks; Unilabs France; University of Birmingham; University of Edinburgh;
 

Conference programme

8:30 Registration & Coffee

9:00 Chairs' Opening Remarks

Anne Whalen

Anne Whalen, Director, Novartis

Blake Green

Blake Green, Director Regulatory Affairs , Amgen
View Bio

9:10 Exploring the medical device global regulatory landscape: impact on the manufacturer

Blake Green

Blake Green, Director Regulatory Affairs , Amgen
View Bio

  • Insight into the impact of the divergent regulatory requirements on the global manufacturer
  • Compare and contrast US and EU Regulatory Frameworks
  • Discussion of how manufacturers could fulfil different
  • Regulations with one holistic approach
  • Assessing the needs of the industry and how to address them
  • 9:50 Key learnings and takeaways from MDR implementation

    Melanie Donguy

    Melanie Donguy, Head Of Regulatory Affairs EMEA, Bayer Radiology
    View Bio

  •  Most important regulatory developments from the MDR implementation
  • Examining the implementation processes: challenges and successes
  • Labelling updates and product supply management
  • Where were the bottlenecks and how were they addressed and overcome?
  • Discussion and review of common approaches and harmonization of regulations
  • 10:30 Morning Coffee

    11:00 Medical Device Development to Commercialisation: Collaborations and Regulations

    Amanda Matthews

    Amanda Matthews, Senior Director, Regulatory Affairs, Pfizer UK Limited
    View Bio

  • What are the biggest challenges when collaborating between medical device and pharma companies?
  • What works well when collaborating across the whole lifecycle management?
  • Clarification of fundamental terms to improve communication (between manufacturers, regulatory bodies and pharma companies)
  • Discussion of the impact of the EU MDR and IVDR and how collaboration can be improved to optimize processes
  • 11:40 An update from the US: Combination Product Requirements

    Prasad Peri

    Prasad Peri, Senior Global Regulatory Affairs CMC, Teva
    View Bio

  • Update on US combination product requirements and transitioning from drug to device
  • Insights into basics of interacting with the FDA and pre-market regulations for medical devices
  • Impact on manufacturers from this guidance
  • 12:20 Networking Lunch

    13:20 The IVDR: What has been learnt so far

    Anne Whalen

    Anne Whalen, Director, Novartis

  • Discussion of the current experience in the industry with the IVDR rollout
  • Requirements for additional guidance in Europe and further IVDR interpretations
  • Exploring the role of notified bodies with the EMA- what is this consultation process?
  • Examining stakeholder challenges and relationships (NBs/ manufacturers/ EMA)
  • 14:00 Industry Outlook on the IVDR and Current state of play

    Joao Martins

    Joao Martins, Associate Director Regulatory Strategy, Abbott
    View Bio

  •  Update on the IVDR implementation: how has it gone and what challenges have arisen?
  • Lessons learnt so far and how these learnings can be applied to the continued rollout
  • Practical approaches to enable manufacturers to comply with the IVDR
  •  

    14:40 Afternoon Tea

    15:10 Requirements and challenges under the IVDR

    Rolf Thermann

    Rolf Thermann, Teamlead CDx, TÜV Rheinland
    View Bio

  •  Regulatory challenges of Companion Diagnostic/Medicine co-development
  • Consultation process: Data requirements to be provided to the Medicinal Authority
  • How to prepare for submissions
  • CDx tumor profiling NGS tests: Many biomarkers, new biomarkers, clinical evidence Companion diagnostics
  • 15:50 Optimising IVDR Technical Documentation Submissions

    Sean O'Callaghan

    Sean O'Callaghan, Senior Scientific Officer - Certification & Inspection, National Standards Authority Of Ireland

  •  Understanding the implications of the Intended Purpose Statement
  • Performance Evaluation – more than 3 Pillars
  • Know your (technical file) audience
  • 16:30 Panel Discussion: Exploring the Present and Future Gaps in Guidance and Regulations for the EU MDR and IVDR

  •  Assessing how industry has adapted to the new EU MDR and IVDR
  • As the industry has evolved what guidance is still needed
  • How can stakeholders collaborate to overcome these challenges
  • How can regulatory bodies keep up with innovations to ensure harmonisation of standards for the advancing field
  • Tom Melvin

    Tom Melvin, Associate Professor of Medical Device Regulatory Affairs, Trinity College Dublin

    Sandra Beltran Rodil

    Sandra Beltran Rodil, Associate Director, Teva Pharmaceuticals Ltd

    Rolf Thermann

    Rolf Thermann, Teamlead CDx, TÜV Rheinland
    View Bio

    Blake Green

    Blake Green, Director Regulatory Affairs , Amgen
    View Bio

    17:10 Chairs' Closing Remarks and Close of Day One

    Blake Green

    Blake Green, Director Regulatory Affairs , Amgen
    View Bio

    Anne Whalen

    Anne Whalen, Director, Novartis

    8:30 Registration & Coffee

    9:00 Chairs' Opening Remarks

    Blake Green

    Blake Green, Director Regulatory Affairs , Amgen
    View Bio

    Anne Whalen

    Anne Whalen, Director, Novartis

    9:10 Navigating the IVDR: Exploring Companion Diagnostics

    Claudia Dollins

    Claudia Dollins, Head, Global Regulatory Sciences, Precision Medicine, Bristol Myers Squibb
    View Bio

  •  What is the definition of a companion diagnostic?
  • Discussion of classification under the IVDR
  • Outline of the regulatory requirements for approval and examples of approval mechanisms
  • IVDR and clinical trial designs: Interface between clinical trial regulation and IVDR
  • 9:50 EU MDR Clinical Aspects: Reviewing the progress of implementation

    Tom Melvin

    Tom Melvin, Associate Professor of Medical Device Regulatory Affairs, Trinity College Dublin

  •  Assessing the clinical aspects of the EU MDR and best practices for compliance
  • Addressing the common challenges for new devices vs. legacy devices
  • Looking into the future: gaps in current guidance and how to address this
  • 10:30 Morning Coffee

    11:00 Regulatory perspective: clinical investigations and performance studies

    Nebojsa Serafimovic

    Nebojsa Serafimovic, Assessor / Delegate, Austrian Medicines and Medical Devices Agency (AGES MEA)
    View Bio

  •  Addressing the key regulations affecting combination products and IVDs under the MDR and IVDR
  • Exploring the Medical Device Coordination Working Groups-Clinical investigation and evaluation guidelines
  • Discussion of EUDAMED clinical investigations and performance studies module
  • How to fulfi l the application submission requirements under EUDAMED
  • 11:40 Complying to the medical device regulations: strategies

    Jim Leamon

    Jim Leamon, Director of Biologics Device Development, Jazz Pharmaceuticals
    View Bio

  •  How can pharma companies work with notified bodies on endpoint expectations for MDR and IVDR compliance
  • Defining the medical device product: what do I have?
  • Medical device life cycle management
  • The impact of implementing the new IVDR and combination product regulations and discussion of their strategies for expanding the QMS to meet manufacturer requirements
  • 12:20 Networking Lunch

    13:20 Post Market Surveillance under the IVDR: Challenges and Solutions

    Marta Carnielli

    Marta Carnielli, IVD Technical Officer, TUV Sud Gmbh
    View Bio

  • Exploring changes to post-marketing surveillance: fulfilling traceability and patient safety
  • Post marketing performance follow up
  • Implementing IVDR post market surveillance for legacy devices
  • Discussion of interaction between the notifi ed body and manufacturer
  • 14:00 implementing effective post market surveillance and vigilance processes: challenges and practical approaches

    Ozlem Pinar  Cetiner

    Ozlem Pinar Cetiner, Associate Director, Patient Safety Digital & Devices, AstraZeneca
    View Bio

  •  Discussion of key PMS and medical device vigilance concepts and requirements
  • Guidance on compiling PMS reports and periodic safety update reports
  • Evaluation of processes, indicators and tools for evaluation and assessment of safety data on medical device quality
  • How to ensure on-time and correct vigilance reporting forsoftware as a medical device
  • Insight into utilising surveillance feedback to identify areas ofcontinuous improvement
  • 14:40 Afternoon Tea

    15:10 EU Regulatory Update: Software as a Medical Device

    Sandra Beltran Rodil

    Sandra Beltran Rodil, Associate Director, Teva Pharmaceuticals Ltd

  •  Exploring the regulatory landscape for software as a medical device under the MDR (classification)
  • Engaging with a notified body
  • Looking at the lifecycle management of software as medical device
  • 15:50 FDA Insight: Cybersecurity is critical: ensuring medical devices are cyber secure

    16:30 Chairs' Closing Remarks and Close of Day Two

    Blake Green

    Blake Green, Director Regulatory Affairs , Amgen
    View Bio

    Anne Whalen

    Anne Whalen, Director, Novartis

    +

    FEATURED SPEAKERS

    Amanda Matthews

    Amanda Matthews

    Senior Director, Regulatory Affairs, Pfizer UK Limited
    Anne Whalen

    Anne Whalen

    Director, Novartis
    Blake Green

    Blake Green

    Director Regulatory Affairs , Amgen
    Claudia Dollins

    Claudia Dollins

    Head, Global Regulatory Sciences, Precision Medicine, Bristol Myers Squibb
    Jim Leamon

    Jim Leamon

    Director of Biologics Device Development, Jazz Pharmaceuticals
    Joao Martins

    Joao Martins

    Associate Director Regulatory Strategy, Abbott
    Marta Carnielli

    Marta Carnielli

    IVD Technical Officer, TUV Sud Gmbh
    Melanie Donguy

    Melanie Donguy

    Head Of Regulatory Affairs EMEA, Bayer Radiology
    Nebojsa Serafimovic

    Nebojsa Serafimovic

    Assessor / Delegate, Austrian Medicines and Medical Devices Agency (AGES MEA)
    Prasad Peri

    Prasad Peri

    Senior Global Regulatory Affairs CMC, Teva
    Sean O'Callaghan

    Sean O'Callaghan

    Senior Scientific Officer - Certification & Inspection, National Standards Authority Of Ireland
    Tom Melvin

    Tom Melvin

    Associate Professor of Medical Device Regulatory Affairs, Trinity College Dublin

    Amanda Matthews

    Senior Director, Regulatory Affairs, Pfizer UK Limited
    Amanda Matthews

     Amanda has 20 years industry experience working at Pfizer, UK. Her career started as an Analytical Chemist before moving into the Regulatory group. For the past 15 years Amanda’s focus has been providing strategic support to global development programs and lifecycle management for a range of medical device and combination products. Amanda is an active participant in industry associations, namely CPC and EFPIA/EBE working groups focusing on drug-device combinations. Amanda is a contributor to ISO/TC84 and worked on the pending ISO 20069 standard for assessment of changes to drug delivery systems as well as contributing to ISO 11608 revisions.

    Anne Whalen

    Director, Novartis
    Anne Whalen

    Blake Green

    Director Regulatory Affairs , Amgen
    Blake Green

     Blake Green is a Regulatory Affairs Senior Director with Amgen’s Global Medical Devices Regulatory team.  Based in the UK, Blake is a Devices Regulatory lead for medicinal product/medical device combination products and co-packaged medical devices in the biopharmaceutical sector.  Prior to joining Amgen, Blake had significant international experience securing multi-national market clearance for manufacturers of medical devices, medical device/medicinal product combinations, medical software, personal protective equipment, and biocides, located throughout the United States of America, European Union, North Africa, Middle East, Far East, Turkey, Israel, Australia, Canada, and Peoples Republic of China. Blake Green is a Regulatory Affairs Senior Director with Amgen’s Global Medical Devices Regulatory team.  Based in the UK, Blake is a Devices Regulatory lead for medicinal product/medical device combination products and co-packaged medical devices in the biopharmaceutical sector.  Prior to joining Amgen, Blake had significant international experience securing multi-national market clearance for manufacturers of medical devices, medical device/medicinal product combinations, medical software, personal protective equipment, and biocides, located throughout the United States of America, European Union, North Africa, Middle East, Far East, Turkey, Israel, Australia, Canada, and Peoples Republic of China.

    Claudia Dollins

    Head, Global Regulatory Sciences, Precision Medicine, Bristol Myers Squibb
    Claudia Dollins

    Claudia Dollins

    Head, Global Regulatory Sciences, Precision Medicine, Bristol Myers Squibb
    Claudia Dollins

     Dr. Dollins currently heads the Global Regulatory Affairs team, Precision Medicine and Companion Diagnostics at Bristol-Myers Squibb. Before joining BMS, she was responsible for the development and implementation of global regulatory strategies of companion diagnostics, medical devices and digital health products in the Merck Healthcare KGaA pipeline.

    She further served as a senior reviewer and acting chief of the hematology branch of the Office of In Vitro Diagnostics and Radiologic Health at the FDA.

     

    Dr. Dollins holds a PhD in Genetics and Genomics from Duke University Medical Center and completed postdoctoral training in Developmental Biology at the University of North Carolina, Chapel Hill. 

    Jim Leamon

    Director of Biologics Device Development, Jazz Pharmaceuticals
    Jim Leamon

     Jim is a medical device and drug device combination product development leader, an engineering director, and a manufacturing manager. He is experienced in working across functions and business groups in varying organizations. Jim has successfully brought new and effective products to market throughout the world and has developed and implemented new engineering, quality control and manufacturing processes. Jim continues to lead product development, and contract engineering teams while working at Jazz Pharmaceuticals. He is highly experienced and proficient in CMC drug-device combination product leadership as well as strategic planning, design engineering, manufacturing engineering and new product and process development. Currently, he is working with Jazz manufacturing teams to expand the availability of a current small cell lung cancer drug product that is in high demand.

    Jim is also a community leader in social justice and feeding the hungry. As treasurer of a non-profit organization, he has used his strategic planning and financial management skills to help people in need. This correlates well with his career drive to improve the lives of cancer patients and those with other life threatening diseases.

     

    Joao Martins

    Associate Director Regulatory Strategy, Abbott
    Joao Martins

     João is a Doctor of Pharmacy (PharmD) and Associate Director Regulatory Strategy at Abbott in Belgium. In his role, he interacts with business units by providing strategic direction and technical guidance on EU MDR/IVDR, Eurasian Economic Union and UK law requirements post Brexit. João also participates to MedTech Europe’s working groups where he has the chance to contribute to shaping the regulatory landscape in the EU. Prior to joining Abbott, he worked for different manufacturers, where he was responsible for implementation of the MDR. João has also experience working with the Middle East region and as a consultant for non-EU manufacturers of MDs/IVDs.

    Marta Carnielli

    IVD Technical Officer, TUV Sud Gmbh
    Marta Carnielli

     Marta Carnielli works for TUV SUD as IVD Technical Director; in this role, she is responsible to gather and distribute regulatory information in the IVD field, represent TÜV SÜD in relevant regulatory committees and conferences and support management and technical experts with the interpretation of regulatory requirements. She is the Co-Chair of the IVD Notified Bodies Working Group

     

    Prior to joining TÜV SÜD, Marta worked for Ortho Clinical Diagnostics where she held various roles of increasing responsibility within Customer Technical Support and the Quality, Regulatory and Compliance department.

    In her most recent role she was Senior Manager, QRC EMEA; in this role she was responsible for quality, regulatory and compliance activities related to the commercial business in Europe, Russia, CIS, Africa and Middle East.

    Melanie Donguy

    Head Of Regulatory Affairs EMEA, Bayer Radiology
    Melanie Donguy

     Mélanie Donguy holds a Pharm D from René Descartes Paris V University and a Master degree in Microbiology . After several years spent in the Pharma Industry within Sanofi, she joined Medtronic in 2010 in regulatory function supporting different business units and being responsible of the implementation of the medical device regulation in EMEA region. She is a subject matter expert in drug device combination products, sterilization and clinical European regulations. Since June 2019 she joined Bayer Radiology as Regulatory Head of medical devices EMEA.

    Nebojsa Serafimovic

    Assessor / Delegate, Austrian Medicines and Medical Devices Agency (AGES MEA)
    Nebojsa Serafimovic

     Mr Nebojsa Serafimovic is an assessor for clinical investigations with medical devices and performance evaluations with in vitro diagnostics. Beside approving studies he is involved in the developement of national processes to takle the MDR and IVDR requirements. Prior to his work at the competent authority, Nebo worked for Philips Austria in medical device engineering and the Medical Response Center. Nebo studied Biomedical Engineering at Graz University of Technology and TGM at Vienna. Nebo is member of the Clinical Investigation and Evaluation Working Group and contributes in a number of taskforces.

    Ozlem Pinar Cetiner

    Associate Director, Patient Safety Digital & Devices, AstraZeneca
    Ozlem Pinar  Cetiner
    Ozlem Pinar Cetiner is an Associate Director, Patient Safety Digital & Devices at AstraZeneca, where she utilises her experience and interest in digital health and medical devices to directly transform patient outcomes. By training, Özlem is a pharmacist with an MSc degree in Pharmacology, and she is a passionate patient safety professional with more than six years of experience. Before joining AstraZeneca, Özlem worked as a Senior Post-Market Surveillance & Vigilance Manager at Ada Health, a Berlin-based leading digital health company, where she successfully implemented an EU MDR-ready post-market surveillance and vigilance system as well as having ensured the development of safe and effective AI-powered health-tech tools. 

    Prasad Peri

    Senior Global Regulatory Affairs CMC, Teva
    Prasad Peri

     S. Prasad Peri is a Senior Director, Global Specialty Regulatory Affairs CMC at Teva Branded Pharmaceutical Products R&D Inc., based in West Chester, PA.  He and his team are responsible for the US Regulatory CMC strategy for Small Molecules, Biologics, Combination Products and Devices.  Prior to joining Teva, Prasad Peri was at Merck and Co. USA as a Director for Global Regulatory Affairs CMC responsible for Combination products and Devices.  Prior to joining Merck, Prasad Peri held the position of a  Branch Chief at the Office of New Drug Quality Assessment within FDA responsible for the CMC review assessment of products submitted to Divisions of Pulmonary, Allergy, Rheumatology, Anesthesia, Analgesia and Addiction.  Prasad Peri holds a Ph.D. in Pharmaceutical Chemistry and a BS in Pharmacy. 

    Rolf Thermann

    Teamlead CDx, TÜV Rheinland
    Rolf Thermann

     Dr. Rolf Thermann is currently a Lead Auditor, Technical Expert and Team Leader Companion Diagnostics at the Notified Body TÜV Rheinland LGA Products GmbH. Within the IVD department he is responsible for regulatory support of Companion Diagnostic products throughout the entire conformity assessment process and interactions with the relevant stakeholders. Dr. Thermann holds a PhD in molecular Medicine and worked in the Pharmaceutical Industry on Antiviral Drug development and in the IVD Industry on the development of PCR-Assays for blood donation testing. 

    Sandra Beltran Rodil

    Associate Director, Teva Pharmaceuticals Ltd
    Sandra Beltran Rodil

    Sean O'Callaghan

    Senior Scientific Officer - Certification & Inspection, National Standards Authority Of Ireland
    Sean O'Callaghan

    Sean O'Callaghan

    Senior Scientific Officer-Certification & Inspection, Medical Devices, National Standards Authority Of Ireland
    Sean O'Callaghan

    Tom Melvin

    Associate Professor of Medical Device Regulatory Affairs, Trinity College Dublin
    Tom Melvin

    Supporters

    VENUE

    Copthorne Tara Hotel

    Scarsdale Place, Kensington, London, United Kingdom

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SAE Media Group. SAE Media Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
    HOTEL BOOKING FORM

    Speaker Biographies

    Download

    Conference Co-Chair Letter

    Download

    Medical Devices and IVD Conference Brochure

    Download

    Media Partners


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    American Pharmaceutical Review

    Supporters
    http://www.americanpharmaceuticalreview.com

    Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    ASD MEDIA

    Supporters
    http://www.asd-network.com

    Professionals in the Aerospace & Defence market use the ASD Media internet platforms to:
    • Be informed on the latest market developments; www.asd-network.com
    • Find the latest business news; www.asd-network.com
    • Find the upcoming events; www.asd-network.com
    • Find companies and organizations; www.asdsource.com
    • Distribute news globally. www.asdwire.com
    The ASD Media platforms are well known and used intensively, your company is able to benefit from these large numbers of users. Be informed with ASD-Network; Create exposure for your company with ASDSource, distribute your news with ASDWire or advertise with us, build your brand and increase traffic to your company’s website.

    For more detailed information please contact with: ASD MEDIA
    Stefan.koopman@asdmedia.nl


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Pharmaceutical Outsourcing

    Supporters
    http://www.pharmoutsourcing.com

    Pharmaceutical Outsourcing, the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry to our 15,000 readers in North America.


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Pharma Journalist

    Supporters
    http://www.pharmajournalist.com

    Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


    Pharmiweb

    Supporters
    http://www.pharmiweb.com

    Established in October 2003, PharmiWeb Solutions is an energetic, innovative provider of web-based solutions for the pharmaceutical sector, with customers such as AstraZeneca, Roche, Servier Laboratories, and Merck With solutions in three key areas: Online Publishing, e-Business and Mobile Computing, we deliver connectivity – between people and applications – unlocking islands of data and knowledge. We own some of the sector’s most innovative Online Publications: PharmiWeb.com, HospitalPharma.com and Detail-Direct.com. We are actively developing solutions for Mobile Computing platforms. For example, our PharmiTabTM e-pharmacy solution runs real-time patient data and prescribing transactions in a busy hospital environment, on a TabletPC, wireless client/server platform. e-Business solutions range from e-Detailing, to Online Market Research, all designed to increase reach, increase sales, and to reduce administration and costs.


    MedTech Innovation

    Supporters
    http://www.med-technews.com

    Med-Tech Innovation is the leading multi-platform communication brand for the UK and Irish medical design and manufacturing industries. Our portfolio includes Med-Tech Innovation Expo an annual exhibition and conference; Med-Tech Innovation News a print magazine and online news source; weekly newsletters and an ever-growing social media community. Med-Tech Innovation reaches a unique medical and healthcare audience eager to source solutions to their latest challenges. We connect innovators – whether they be major OEMs or fledgling start-ups –with a community of designers and engineers ready to help bring medical devices to market, quickly and at scale.


    Mass Device

    Supporters
    https://www.massdevice.com/

    MassDevice provides day-to-day coverage of the medtech and medical device industry, with stories about devices that save lives, the people behind them and the trends driving businesses forward. Our reach extends across the industry, with up-to-date news on clinical trials, regulatory processes research and development, financial updates and legal news for spaces including orthopedic devices, surgical robotics, replacement heart valves and plenty more. We’re the most trusted resource in the medical device industry that’s inside the boardroom of every medical device company in the country. Our fully interactive brand focuses on covering the ways in which medtech businesses are offering safer, more effective and cost-efficient treatments around the world. The publication serves the medtech and medical device industry, supplier and contract manufacturers, government organizations/agencies, research hospitals, medical centers, universities and more. Our readers include high-level medtech executives, trade associations, entrepreneurs, corporate and academic researchers, engineers and government officials including regulators. MassDevice is your top resource for all medical device and medtech news, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers.


    International Pharmaceutical Industry (IPI)

    Supporters
    http://ipimediaworld.com/

    IPI – International Pharmaceutical Industry IPI – was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally. Edited by our carefully selected editorial advisory panel, and extensive research network, IPI provides a proven supportive means of communication to the pharmaceutical, bio pharmaceutical, nutraceutical and medical devices industry the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies which will enable them to be more efficient, bring products to market faster, reduce cost and make healthcare accessible to all.

    SAVE TO


    Outlook Calendar  OUTLOOK CALENDAR
    Google Calendar  GOOGLE CALENDAR
    ICal Calendar  ICAL CALENDAR
    Yahoo! Calendar  YAHOO! CALENDAR

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out